BMY-CELG’s CVR* -28% on bb2121 RTF letter. For the $9/sh payout to occur to CVR holders, bb2121 must receive FDA approval by 3/31/21 (#msg-145844551). BMY/BLUE PR on today’s news: https://www.businesswire.com/news/home/20200513005210/en There was a CC this morning (I didn’t listen). *Ticker symbol is BMY-RI on Yahoo Finance.